Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282691 · ClinicalTrials.gov registry record
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
A clinical trial of mTBI - Mild Traumatic Brain Injury, sponsored by Salus University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07282691 is a study of mTBI - Mild Traumatic Brain Injury that is actively recruiting participants, run by Salus University. The registered enrollment target is 150 participants, below the 206-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07282691, a study of mTBI - Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by Salus University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Conditions Studied
Study Locations (1)
Pennsylvania
- The Eye Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07282691
The ClinicalTrials.gov registry entry for NCT07282691 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (27% lower). The listed sponsor is Salus University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with mTBI - Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT07282691 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07282691 about?
NCT07282691 is a clinical study titled "Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders". The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
What is the current status of trial NCT07282691?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-04-01. Estimated completion is 2028-09-29.
What conditions does trial NCT07282691 study?
This clinical trial studies the following conditions: mTBI - Mild Traumatic Brain Injury.
Who is sponsoring clinical trial NCT07282691?
This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282691 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for mTBI - Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MindRhythm Detection of Concussion and Recovery Study
RECRUITING
-
Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury
ACTIVE NOT RECRUITING · NA
-
Follow-up of MTBI Patients Discharged from the ED Using Standard Clinical Triage Including BrainScope One
ACTIVE NOT RECRUITING
-
Evaluation of Helmet Technology and Head Impact Exposure
COMPLETED · NA
-
Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology
COMPLETED · NA
-
Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.